The BioIntelliSense Data-as-a-Service (DaaS) platform and FDA-cleared BioSticker™ on-body sensor are bringing medical grade monitoring and management to the home for scalable remote care.
More News
Smartphone apps, wearable trackers helped people with heart disease boost physical activity
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
